secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2023-03-03T23:59:59+00:00
Accession:  0001493152-23-006692
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ZyVersa amends license agreement with L&F Research, waives termination rights on $1.5M milestone payments
--------------------------------------------------------------------------------

- LFR waives termination rights for $1M milestone payments until March 31, 2023, contingent on ZyVersa forgiving $351,579 note and paying $648,421 cash.
- LFR waives termination rights for $500K milestone payment until Jan 31, 2024 or 10 days after ZyVersa raises $30M equity.
- ZyVersa to forgive $351,579 promissory note from LFR as part of consideration for the waiver.
- Put option agreement between ZyVersa and LFR will expire upon forgiveness of the note.
- If conditions not met, waivers become void and original payment obligations reinstated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000149315223006692/0001493152-23-006692-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000149315223006692/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-006692

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer